Molecular Templates Competitors, Revenue, Alternatives and Pricing

Claim your profile


Austin, TX USA
Total Funding:$93.5M
Lead Investor(s):N/A

City Ranking

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Molecular Templates's estimated annual revenue is currently $2147.5M per year.(?)
  • Molecular Templates's estimated revenue per employee is $9,896,238
  • Molecular Templates's total funding is $93.5M.

Employee Data

  • Molecular Templates has 217 Employees.(?)
  • Molecular Templates grew their employee count by 27% last year.
  • Molecular Templates currently has 22 job openings.

Molecular Templates (MTEM) is a clinical-stage biopharmaceutical company targeting a variety of cancers through development of its innovative proprietary Engineered Toxin Body (ETB) platform. MTEM's first immunotoxin, MT-3724, is in clinical development for non-Hodgkin's lymphoma. Pipeline products for additional oncology targets are being advanced toward clinical development. For more information, please visit MTEM's website at